Information about Vivoryon Therapeutics
My details
*
*
*

Vivoryon Therapeutics (SA)

nl

81075480

Company information

Status
Active

KVK number

81075480

VAT Number

NL 861917583 B01
Established
28-11-2020
Last balance sheet year
2023
Company size
Big 17 FTE
Legal form
Société anonyme (SA)
RSIN number
861917583
Principal activity
Natuurwetenschappelijk onderzoek en experimentele ontwikkeling
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Vivoryon Therapeutics

2023 2021 2020
Profit/Loss € -28.342.000 -123,96% € -12.655.000 -
Turnover € -3.620.000 -133,63% € 10.764.000 -
Equity € 26.282.000 58,74% € 16.557.000 -36,86% € 26.221.000
Gross margin € -3.095.000 -133,66% € 9.196.000 > 1000% € 6.000
Employees 17 15 16

Frequently asked questions

What is the KVK number of Vivoryon Therapeutics?
The KVK number of Vivoryon Therapeutics is 81075480
What is the VAT number of Vivoryon Therapeutics?
The VAT number of Vivoryon Therapeutics is NL 861917583 B01.
Wat is the PEPPOL ID of Vivoryon Therapeutics?
There is no information available about the PEPPOL ID of Vivoryon Therapeutics or the company is not yet registered on the PEPPOL network.
When was Vivoryon Therapeutics founded?
Vivoryon Therapeutics was founded on 28-11-2020.
What is the address of Vivoryon Therapeutics?
The current registered office of Vivoryon Therapeutics is located at Weinbergweg 22 06120 Halle Bondsrepubliek Duitsland.
When was the last time Vivoryon Therapeutics filed their annual financial statements?
The most recent financial statements of Vivoryon Therapeutics were filed on 31-12-2023.
How many employees does Vivoryon Therapeutics have?
There are 17 FTEs working at Vivoryon Therapeutics according to the staff figures in the most recent financial statements.
What is the annual turnover of Vivoryon Therapeutics?
At the time of its most recent financial statements, Vivoryon Therapeutics recorded a total turnover of -€3.620.000,00.

Sources